Shanghai Pharmaceutical announced that its subsidiary Shanghai Pharmaceutical Holdings plans to transfer 41% of the shares of the holding subsidiary Shangyao Yiyao Pharmaceutical Co., Ltd. through public listing on the property rights exchange. The proposed listing transfer price is RMB 330 million. After the transaction is completed, Shanghai Pharmaceutical will hold 10% of the shares in the target company and will no longer be listed.

Shanghai Pharmaceutical announced that its subsidiary Shanghai Pharmaceutical Holdings plans to transfer 41% of the shares of the holding subsidiary Shangyao Yiyao Pharmaceutical Co., Ltd. through public listing on the property rights exchange. The proposed listing transfer price is RMB 330 million. After the transaction is completed, Shanghai Pharmaceutical will hold 10% of the shares in the target company and will no longer be listed.